Search All News
If untreated, glaucoma can lead to irreversible vision loss. A Columbia screening program is finding more people with the disease than expected.
An initiative led by a Columbia ophthalmologist seeks to improve the treatment of eye trauma, a serious but neglected condition second only to cataracts as the most common cause of visual impairment.
Steven E. Rosenberg, MD, an expert in strabismus and pediatric ophthalmology, joins Columbia.
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
- May 3, 2018
Neuroscientist Carol Mason, PhD, was elected to the National Academy of Sciences along with 104 other new members and foreign associates.
- September 27, 2017
Columbia Ophthalmology's new tele-ophthalmology van will screen, free of charge, 2,000 NYC residents each year for major sight-threatening conditions.
- August 18, 2017
CUMC ophthalmologist Tongalp Tezel has tips to protect your vision during a solar eclipse, including why taking a selfie with the sun is a bad idea.
- May 30, 2017
Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.
- April 19, 2017
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
- November 14, 2016
Columbia University researchers slowed vision loss in mice who have a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.
- November 5, 2015
Eye damage from high-power lasers can masquerade as genetic eye diseases and lead to costly work-ups, Columbia ophthalmologists find.
- July 10, 2014
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.